These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7545423)

  • 1. In vivo effects of interleukin-11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis.
    de Haan G; Dontje B; Engel C; Loeffler M; Nijhof W
    Br J Haematol; 1995 Aug; 90(4):783-90. PubMed ID: 7545423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11.
    Hassan HT; Biermann B; Zander AR
    Eur Cytokine Netw; 1996; 7(2):129-36. PubMed ID: 8688490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual inhibition of murine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: in vivo interactions and dose-response surfaces.
    de Haan G; Engel C; Dontje B; Nijhof W; Loeffler M
    Blood; 1994 Dec; 84(12):4157-63. PubMed ID: 7527670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RAR-RXR as well as the RXR-RXR pathway is involved in signaling growth inhibition of human CD34+ erythroid progenitor cells.
    Rusten LS; Dybedal I; Blomhoff HK; Blomhoff R; Smeland EB; Jacobsen SE
    Blood; 1996 Mar; 87(5):1728-36. PubMed ID: 8634418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
    Arcasoy MO; Jiang X
    Br J Haematol; 2005 Jul; 130(1):121-9. PubMed ID: 15982354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of erythropoietin and recombinant cytokines on colony formation and self-renewal by erythroid burst-forming units and granulocyte-macrophage progenitors from mobilized peripheral blood progenitor cells.
    Zheng B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):6-12. PubMed ID: 12513828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of continuous stem cell factor administration on normal and erythropoietin-stimulated murine hemopoiesis: experimental results and model analysis.
    de Haan G; Dontje B; Nijhof W; Loeffler M
    Stem Cells; 1995 Jan; 13(1):65-76. PubMed ID: 7536513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of human recombinant erythropoietin on differentiation and distribution of erythroid progenitor cells on murine medullary and splenic erythropoiesis during hypoxia and post-hypoxia.
    Mide SM; Huygens P; Bozzini CE; Fernandez Pol JA
    In Vivo; 2001; 15(2):125-32. PubMed ID: 11317516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin.
    Muta K; Krantz SB
    J Cell Physiol; 1993 Aug; 156(2):264-71. PubMed ID: 7688370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
    Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
    J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The erythropoietic effects of interleukin 6 and erythropoietin in vivo.
    Ulich TR; del Castillo J; Yin SM; Egrie JC
    Exp Hematol; 1991 Jan; 19(1):29-34. PubMed ID: 1989892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen.
    Broudy VC; Lin NL; Priestley GV; Nocka K; Wolf NS
    Blood; 1996 Jul; 88(1):75-81. PubMed ID: 8704204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of stem-cell factor, interleukin-3 and erythropoietin on in vitro erythropoiesis in myelodysplastic syndromes.
    Verbeek W; Vehmeyer K; Wörmann B; Hiddemann W
    J Cancer Res Clin Oncol; 1995; 121(6):338-42. PubMed ID: 7797598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vanadate mimics the effect of stem cell factor on highly purified human erythroid burst-forming units in vitro, but not the effect of erythropoietin.
    Dai CH; Krantz S
    Exp Hematol; 1992 Oct; 20(9):1055-60. PubMed ID: 1281783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta (TGF-beta), a potent inhibitor of erythropoiesis: neutralizing TGF-beta antibodies show erythropoietin as a potent stimulator of murine burst-forming unit erythroid colony formation in the absence of a burst-promoting activity.
    Dybedal I; Jacobsen SE
    Blood; 1995 Aug; 86(3):949-57. PubMed ID: 7542505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.